{"id":"https://openalex.org/W2886730071","doi":"https://doi.org/10.1158/1557-3125.advbc17-a50","title":"Abstract A50: Modeling and targeting of oncogenic proteotoxic stress in drug-resistant breast cancer","display_name":"Abstract A50: Modeling and targeting of oncogenic proteotoxic stress in drug-resistant breast cancer","publication_year":2018,"publication_date":"2018-08-01","ids":{"openalex":"https://openalex.org/W2886730071","doi":"https://doi.org/10.1158/1557-3125.advbc17-a50","mag":"2886730071"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.advbc17-a50","doi":"https://doi.org/10.1158/1557-3125.advbc17-a50","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.advbc17-a50","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016067866","display_name":"Navneet Singh","orcid":"https://orcid.org/0000-0002-8389-0701","observed_orcids":["https://orcid.org/0000-0002-8389-0701","https://orcid.org/0009-0004-1818-4706"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Navneet Singh","raw_affiliation_strings":["Cincinnati Childrens Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cincinnati Childrens Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005625979","display_name":"Vishnu Modur","orcid":"https://orcid.org/0000-0002-5422-2552","observed_orcids":["https://orcid.org/0000-0002-5422-2552"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vishnu Modur","raw_affiliation_strings":["Cincinnati Childrens Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cincinnati Childrens Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048857351","display_name":"Belal A. Muhammad","orcid":"https://orcid.org/0000-0001-6952-0571","observed_orcids":["https://orcid.org/0000-0001-6952-0571"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Belal Muhammad","raw_affiliation_strings":["Cincinnati Childrens Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cincinnati Childrens Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061302509","display_name":"Kakajan Komurov","orcid":"https://orcid.org/0000-0003-4834-9845","observed_orcids":["https://orcid.org/0000-0003-4834-9845"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kakajan Komurov","raw_affiliation_strings":["Cincinnati Childrens Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cincinnati Childrens Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1285204247"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"8_Supplement","first_page":"A50","last_page":"A50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8765000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8765000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11150","display_name":"Endoplasmic Reticulum Stress and Disease","score":0.049400001764297485,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.011599999852478504,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9670000076293945},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7919999957084656},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8410000205039978},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":1.0},{"id":"https://openalex.org/keywords/er-associated-degradation","display_name":"ER-associated degradation","score":0.8619999885559082},{"id":"https://openalex.org/keywords/proteotoxic-stress","display_name":"proteotoxic stress","score":0.9079999923706055},{"id":"https://openalex.org/keywords/endoplasmic-reticulum-stress","display_name":"endoplasmic reticulum stress","score":0.906000018119812},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.9850000143051147},{"id":"https://openalex.org/keywords/proteostasis","display_name":"proteostasis","score":0.9649999737739563},{"id":"https://openalex.org/keywords/acquired-resistance","display_name":"acquired resistance","score":0.4740000069141388},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7350000143051147},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.6470000147819519},{"id":"https://openalex.org/keywords/system-modeling","display_name":"system modeling","score":0.5600000023841858},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.527999997138977},{"id":"https://openalex.org/keywords/protein-synthesis-rate","display_name":"protein synthesis rate","score":0.5230000019073486},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.5889999866485596},{"id":"https://openalex.org/keywords/targeted-therapy-resistance","display_name":"targeted therapy resistance","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.9372687935829163},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7676655054092407},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5825615525245667},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5802159309387207},{"id":"https://openalex.org/C139447449","wikidata":"https://www.wikidata.org/wiki/Q14633900","display_name":"Unfolded protein response","level":3,"score":0.5784823298454285},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5471455454826355},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5130776166915894},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.48896777629852295},{"id":"https://openalex.org/C158619295","wikidata":"https://www.wikidata.org/wiki/Q21101062","display_name":"Endoplasmic-reticulum-associated protein degradation","level":4,"score":0.467864990234375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4168056845664978},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4122962951660156},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3940889239311218},{"id":"https://openalex.org/C158617107","wikidata":"https://www.wikidata.org/wiki/Q79927","display_name":"Endoplasmic reticulum","level":2,"score":0.3862813413143158},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3562425971031189},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20915764570236206},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.16761383414268494},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.advbc17-a50","doi":"https://doi.org/10.1158/1557-3125.advbc17-a50","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.advbc17-a50","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2566678717","https://openalex.org/W2122972184","https://openalex.org/W2101938961","https://openalex.org/W4311589178","https://openalex.org/W2275827194","https://openalex.org/W4392768445","https://openalex.org/W4393075284","https://openalex.org/W4407405512","https://openalex.org/W2886021455","https://openalex.org/W2975421261"],"abstract_inverted_index":{"Abstract":[0],"ERBB2/HER2-positive":[1],"breast":[2,87,315],"cancers":[3],"are":[4,23,196],"associated":[5,197,270],"with":[6,198,271],"poor":[7],"prognosis,":[8],"and":[9,15,138,165,175,186,193,245,282,307],"resistance":[10,185,278],"to":[11,55,93,114,222,257,279],"HER2-targeted":[12,35],"therapy":[13],"(trastuzumab":[14],"lapatinib)":[16],"presents":[17],"a":[18,72],"significant":[19],"clinical":[20],"hurdle.":[21],"There":[22],"no":[24],"treatment":[25,195],"options":[26],"for":[27,143,287],"metastatic":[28],"HER2+":[29],"BCs":[30,49,80,102],"that":[31,61,100,183],"have":[32,59,103,159],"progressed":[33],"on":[34,43,51,106,218],"therapy.":[36,180],"At":[37],"present,":[38],"most":[39],"of":[40,63,79,127,134,146,163,178,189,201,234,260,267,290,309,320],"the":[41,107,116,125,132,144,149,161,184,219,232,242,258,265,272,288,321],"research":[42],"therapeutic":[44,74,141,285],"strategies":[45],"in":[46,76,148,169,214,241,292,313,326],"therapy-refractory":[47,150,293],"Her2+":[48,101,151,170,294],"focuses":[50],"resensitizing":[52],"tumor":[53],"cells":[54,89,171,235,240],"HER2-targeting":[56],"agents.":[57],"We":[58,98,181],"shown":[60],"targeting":[62,145,289,308],"nononcogenic":[64],"vulnerabilities,":[65],"specifically":[66],"adaptive":[67],"proteotoxic":[68,120,216,311],"stress":[69,312],"response,":[70],"is":[71],"promising":[73],"approach":[75],"this":[77],"subset":[78],"(Singh":[81],"N.":[82],"et":[83],"al,":[84],"HER2-mTOR":[85],"signaling-driven":[86],"cancer":[88,316],"require":[90],"ER-associated":[91],"degradation":[92,111],"survive.":[94],"Science":[95],"Signaling":[96],"2015).":[97],"showed":[99,253],"specific":[104],"dependence":[105],"endoplasmic":[108],"reticulum":[109],"(ER)-associated":[110],"(ERAD)":[112],"pathway":[113,210,274],"suppress":[115],"hyperactive":[117],"Her2/mTOR":[118],"pathway-driven":[119],"stress.":[121],"Here,":[122],"we":[123,158],"explore":[124],"kinetics":[126,266],"protein":[128,166,224,268],"homeostatic":[129],"changes":[130,168,211,275],"during":[131,172,276],"course":[133],"Her2-targeted":[135,179],"drug":[136,191,251],"therapy,":[137,281],"identify":[139],"optimal":[140,284],"windows":[142,286],"ERAD":[147,291],"BCs.":[152,295],"Using":[153],"an":[154],"integrated":[155],"systems":[156],"approach,":[157],"modeled":[160],"dynamics":[162],"signaling":[164,209,273],"homeostasis":[167,269],"remission,":[173],"resistance,":[174],"relapse":[176,187,243],"phases":[177,188],"found":[182],"anti-Her2":[190,237,280],"(lapatinib":[192],"trastuzumab)":[194],"Her2-independent":[199],"acquisition":[200],"mTOR":[202],"signaling,":[203],"as":[204],"previously":[205],"reported.":[206],"However,":[207],"these":[208],"also":[212],"resulted":[213],"heightened":[215,255],"burden":[217],"ER":[220],"due":[221],"increased":[223],"synthesis":[225],"rates,":[226],"which":[227],"was":[228],"further":[229,250],"exacerbated":[230],"upon":[231,249],"release":[233],"from":[236],"treatment.":[238],"Accordingly,":[239],"phase,":[244],"even":[246],"more":[247],"so":[248],"withdrawal,":[252],"significantly":[254],"sensitivity":[256],"inhibition":[259],"ERAD.":[261],"This":[262],"study":[263],"reveals":[264],"acquired":[277],"suggests":[283],"Citation":[296],"Format:":[297],"Navneet":[298],"Singh,":[299],"Vishnu":[300],"Modur,":[301],"Belal":[302],"Muhammad,":[303],"Kakajan":[304],"Komurov.":[305],"Modeling":[306],"oncogenic":[310],"drug-resistant":[314],"[abstract].":[317],"In:":[318],"Proceedings":[319],"AACR":[322],"Special":[323],"Conference:":[324],"Advances":[325],"Breast":[327],"Cancer":[328,339],"Research;":[329],"2017":[330],"Oct":[331],"7-10;":[332],"Hollywood,":[333],"CA.":[334],"Philadelphia":[335],"(PA):":[336],"AACR;":[337],"Mol":[338],"Res":[340],"2018;16(8_Suppl):Abstract":[341],"nr":[342],"A50.":[343]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2018-08-22T00:00:00"}